180 related articles for article (PubMed ID: 35681235)
1. CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathway.
Del Gaudio N; Di Costanzo A; Liu NQ; Conte L; Dell'Aversana C; Bove G; Benedetti R; Montella L; Ciardiello F; Carafa V; Ambrosino C; Tucci V; Conte M; Martens JHA; Stunnenberg HG; Nebbioso A; Altucci L
Mol Cancer; 2022 Jun; 21(1):125. PubMed ID: 35681235
[TBL] [Abstract][Full Text] [Related]
2. The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia.
Di Costanzo A; Del Gaudio N; Conte L; Dell'Aversana C; Vermeulen M; de Thé H; Migliaccio A; Nebbioso A; Altucci L
Oncogene; 2018 May; 37(19):2559-2572. PubMed ID: 29467492
[TBL] [Abstract][Full Text] [Related]
3. Nuclear condensates of the Polycomb protein chromobox 2 (CBX2) assemble through phase separation.
Tatavosian R; Kent S; Brown K; Yao T; Duc HN; Huynh TN; Zhen CY; Ma B; Wang H; Ren X
J Biol Chem; 2019 Feb; 294(5):1451-1463. PubMed ID: 30514760
[TBL] [Abstract][Full Text] [Related]
4. Cbx2 stably associates with mitotic chromosomes via a PRC2- or PRC1-independent mechanism and is needed for recruiting PRC1 complex to mitotic chromosomes.
Zhen CY; Duc HN; Kokotovic M; Phiel CJ; Ren X
Mol Biol Cell; 2014 Nov; 25(23):3726-39. PubMed ID: 25232004
[TBL] [Abstract][Full Text] [Related]
5. Prognostic hub gene CBX2 drives a cancer stem cell-like phenotype in HCC revealed by multi-omics and multi-cohorts.
Meng Q; Zhou Q; Chen X; Chen J
Aging (Albany NY); 2023 Nov; 15(22):12817-12851. PubMed ID: 37980163
[TBL] [Abstract][Full Text] [Related]
6. Cell type-specific role of CBX2 and its disordered region in spermatogenesis.
Kim JJ; Steinson ER; Lau MS; de Rooij DG; Page DC; Kingston RE
Genes Dev; 2023 Jul; 37(13-14):640-660. PubMed ID: 37553262
[TBL] [Abstract][Full Text] [Related]
7. The Epigenetic Regulatory Protein CBX2 Promotes mTORC1 Signalling and Inhibits DREAM Complex Activity to Drive Breast Cancer Cell Growth.
Bilton LJ; Warren C; Humphries RM; Kalsi S; Waters E; Francis T; Dobrowinski W; Beltran-Alvarez P; Wade MA
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884550
[TBL] [Abstract][Full Text] [Related]
8. Tetraspanin Family Member, CD82, Regulates Expression of EZH2 via Inactivation of p38 MAPK Signaling in Leukemia Cells.
Nishioka C; Ikezoe T; Yang J; Yokoyama A
PLoS One; 2015; 10(5):e0125017. PubMed ID: 25955299
[TBL] [Abstract][Full Text] [Related]
9. PPM1D Knockdown Suppresses Cell Proliferation, Promotes Cell Apoptosis, and Activates p38 MAPK/p53 Signaling Pathway in Acute Myeloid Leukemia.
Li B; Hu J; He D; Chen Q; Liu S; Zhu X; Yu M
Technol Cancer Res Treat; 2020; 19():1533033820942312. PubMed ID: 32691668
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of CBX2 controls its nucleosome-binding specificity.
Kawaguchi T; Machida S; Kurumizaka H; Tagami H; Nakayama JI
J Biochem; 2017 Nov; 162(5):343-355. PubMed ID: 28992316
[TBL] [Abstract][Full Text] [Related]
11. Beyond EZH2: is the polycomb protein CBX2 an emerging target for anti-cancer therapy?
Jangal M; Lebeau B; Witcher M
Expert Opin Ther Targets; 2019 Jul; 23(7):565-578. PubMed ID: 31177918
[No Abstract] [Full Text] [Related]
12. CBX2 is required to stabilize the testis pathway by repressing Wnt signaling.
Garcia-Moreno SA; Lin YT; Futtner CR; Salamone IM; Capel B; Maatouk DM
PLoS Genet; 2019 May; 15(5):e1007895. PubMed ID: 31116734
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide identification of CBX2 targets: insights in the human sex development network.
Eid W; Opitz L; Biason-Lauber A
Mol Endocrinol; 2015 Feb; 29(2):247-57. PubMed ID: 25569159
[TBL] [Abstract][Full Text] [Related]
14. A Potent, Selective CBX2 Chromodomain Ligand and Its Cellular Activity During Prostate Cancer Neuroendocrine Differentiation.
Wang S; Alpsoy A; Sood S; Ordonez-Rubiano SC; Dhiman A; Sun Y; Jiao G; Krusemark CJ; Dykhuizen EC
Chembiochem; 2021 Jul; 22(13):2335-2344. PubMed ID: 33950564
[TBL] [Abstract][Full Text] [Related]
15. Cbx2 targets PRC1 to constitutive heterochromatin in mouse zygotes in a parent-of-origin-dependent manner.
Tardat M; Albert M; Kunzmann R; Liu Z; Kaustov L; Thierry R; Duan S; Brykczynska U; Arrowsmith CH; Peters AH
Mol Cell; 2015 Apr; 58(1):157-71. PubMed ID: 25801166
[TBL] [Abstract][Full Text] [Related]
16. A human Polycomb isoform lacking the Pc box does not participate to PRC1 complexes but forms protein assemblies and represses transcription.
Völkel P; Le Faou P; Vandamme J; Pira D; Angrand PO
Epigenetics; 2012 May; 7(5):482-91. PubMed ID: 22419124
[TBL] [Abstract][Full Text] [Related]
17. CBX2 is a functional target of miRNA let-7a and acts as a tumor promoter in osteosarcoma.
Han Q; Li C; Cao Y; Bao J; Li K; Song R; Chen X; Li J; Wu X
Cancer Med; 2019 Jul; 8(8):3981-3991. PubMed ID: 31150156
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic Regulation of Bmi1 by Ubiquitination and Proteasomal Degradation Inhibit Bcl-2 in Acute Myeloid Leukemia.
Kushwaha AC; Mohanbhai SJ; Sardoiwala MN; Sood A; Karmakar S; Roy Choudhury S
ACS Appl Mater Interfaces; 2020 Jun; 12(23):25633-25644. PubMed ID: 32453568
[TBL] [Abstract][Full Text] [Related]
19. Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1.
Darwish NH; Sudha T; Godugu K; Elbaz O; Abdelghaffar HA; Hassan EE; Mousa SA
Oncotarget; 2016 Sep; 7(36):57811-57820. PubMed ID: 27506934
[TBL] [Abstract][Full Text] [Related]
20. Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer.
Clermont PL; Crea F; Chiang YT; Lin D; Zhang A; Wang JZ; Parolia A; Wu R; Xue H; Wang Y; Ding J; Thu KL; Lam WL; Shah SP; Collins CC; Wang Y; Helgason CD
Clin Epigenetics; 2016; 8():16. PubMed ID: 26877821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
